Clyde Biosciences is a company headquartered in the United Kingdom.
Clyde Biosciences is a Glasgow-based contract research organization that provides in vitro cardiomyocyte assays using its CellOPTIQ® platform to measure electrophysiology, calcium dynamics, and contractility in human iPSC-derived cardiomyocytes. The company delivers cardiac safety and drug discovery services aligned with regulatory CiPA guidance to pharmaceutical and biotech clients.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.